The definition of the roles of Mstn and Act-A in the pathogenesis of atherosclerosis, vascular calcification, and CKD-MBD may provide the rationale to design original therapeutic strategies that could be complementary to current treatments that are often not fully satisfactory. Here, MSTN is linked to chronic kidney disease.